2021. Mild clinical course of COVID-19 infection in chronic myeloid leukemia (CML) patients receiving tyrosine kinase inhibitors (TKIs) without interruption. Mediterranean Journal of Hematology and Infectious Diseases. 13, 1 (Feb. 2021), e2021022. DOI:https://doi.org/10.4084/mjhid.2021.022.